NAMSA BRINGS 50 YEARS OF TESTING LEADERSHIP TO GERMANY
NAMSA Created the Medical Device Testing Industry
As the creator of the medical device testing industry and marketplace leader for over 50 years, NAMSA is pleased to announce the opening of its new Analytical Services Laboratory in Obernburg, Germany. Now offering European manufacturers a centrally-located partner for ISO 10993-18 requirements, our state-of-the-art laboratory will provide further convenience for testing services for exhaustive extraction, FTIR, GC-MS, LC-MS and ICP-MS.
About NAMSA Testing Services
NAMSA offers a comprehensive range of analytical chemistry testing services to help ensure product safety, quality, and consistency during all stages of the device development lifecycle. Our team of testing experts works uniquely with each client to design and implement testing programs to achieve high-quality outcomes, and to minimize unneeded testing, drastically reducing timelines and costs.
What’s more, NAMSA is the only existing Medical Research Organization (MRO®) in the world that supports clients throughout all stages of the medical device development continuum. From concept and feasibility testing to post-market surveillance, services provided by NAMSA have been proven to accelerate time-to-market and reduce costs related to medical device testing, clinical research and regulatory strategy. By leveraging a half century of scientific expertise, and drawing upon 1,000 highly-experienced global Associates, we are “the” experts at balancing speed and quality with proven scientific approaches.
Additional Medical Device Testing Resources
As the premier medical device development partner, NAMSA provides various learning opportunities that share our knowledge gained through thousands of testing efforts around the globe. We invite you to access our latest educational pieces to learn more about current and forthcoming testing requirements and standards.
- White Paper
Reducing Medical Device Development Timelines and Creating Value Through Biological Risk Assessments and Chemical Characterization
ISO 10993 Update: Understanding the Use and Value of Biocompatibility Standards for Medical Devices
The Purpose and Value of Chemical Characterization and Biological Risk Assessment in Medical Device Development
- NAMSA’s Test Navigator: Access our online test selection tool to gain visibility into NAMSA’s testing capabilities. Included is information on the most commonly used tests, in addition to testing services provided for special test and study requirements.
Certifications and Registrations
(Obernburg, Germany Laboratory)
- DIN EN ISO/IEC 17025 accreditation in progress.
- ZLG recognition in progress.